1-2 of 2
Mitsue Inomata, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-Line Dasatinib Treatment of CML-CP Leads to Earlier Achievement of MMR and MR4.5 with High Safety

Kazunori Murai, MD, PhD, Kohei Yamaguchi, MD, Shigeki Ito, MD, PhD, Takuto Miyagishima, MD, PhD, Motohiro Shindo, MD PhD, Kentaro Wakasa, MD, PhD, Mitsue Inomata, MD, PhD, Takahiro Nagashima, MD, PhD, Takeshi Kondo, MD PhD, Nozomu Fujimoto, MD, PhD, Satoshi Yamamoto, PhD MD, Masakatsu Yonezumi, MD, PhD, Tatsuo Oyake, MD, PhD, Shugo Kowata, MD PhD, Yasuhiko Tsukushi, MD PhD, Takahiro Mine, MD, Kuniaki Meguro, MD PhD, Kazuhiko Ikeda, MD PhD, Reiko Watanabe, MD PhD, Souichi Saito, MD, PhD, Shinji Sato, MD, PhD, Takaaki Chou, MD, PhD, Kohmei Kubo, MD, PhD, Koji Oba, PhD, Junichi Sakamoto, MDPhD, Yoji Ishida, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3102.
https://doi.org/10.1182/blood.V128.22.3102.3102
Published: 2016
Journal Articles

Inverse Correlation between Flt3 and PU.1 Expression in Acute Myeloblastic Leukemias.

Shinichiro Takahashi, MD, PhD, Mitsue Inomata, MD, Hideo Harigae, MD, PhD, Junichi Kameoka, MD, PhD, Mitsuo Kaku, MD, PhD, Takeshi Sasaki, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1209.
https://doi.org/10.1182/blood.V106.11.1209.1209
Published: 2005